Amphastar Pharmaceuticals Net Worth 2012-2024 | AMPH

Interactive chart of historical net worth (market cap) for Amphastar Pharmaceuticals (AMPH) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Amphastar Pharmaceuticals net worth as of February 21, 2025 is $1.5B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.501B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.441B 7.12
Dr Reddy's Laboratories (RDY) India $11.160B 21.29
BridgeBio Pharma (BBIO) United States $6.858B 0.00
Bausch Health Cos (BHC) Canada $2.354B 1.71
Supernus Pharmaceuticals (SUPN) United States $1.851B 25.20
Personalis (PSNL) United States $0.412B 0.00
Taysha Gene Therapies (TSHA) United States $0.336B 23.43
Assembly Biosciences (ASMB) United States $0.081B 0.00
Sol-Gel Technologies (SLGL) Israel $0.016B 0.00
Evoke Pharma (EVOK) United States $0.008B 0.00
Teligent (TLGT) United States $0.000B 0.00